Introduction
The endocrine system is composed of glands that secrete hormones directly into the bloodstream to regulate metabolism, growth and development, tissue function, sexual function, reproduction, sleep, and mood among many other important functions. When the delicate balance of hormones is disrupted, it can lead to a variety of endocrine problems and disorders. The goal of this thesis research paper is to explore some of the most common and clinically significant endocrine problems, with a focus on their underlying pathophysiology, clinical presentation, diagnosis, and treatment options.
Thyroid Disorders
Thyroid disorders are among the most prevalent endocrine problems seen in clinical practice. The thyroid gland, located at the base of the neck, is responsible for producing the hormones triiodothyronine (T3) and thyroxine (T4) which regulate metabolism.
Hypothyroidism
Hypothyroidism, or underactivity of the thyroid gland, affects around 5% of the population, with women afflicted 4-8 times more often than men (Abel & Cockcroft, 2018). It occurs when the thyroid does not produce enough thyroid hormones. Common causes include Hashimoto’s thyroiditis (an autoimmune disease causing gradual destruction of the thyroid), surgical or medical thyroid ablation for hyperthyroidism or thyroid cancer treatment, radiation exposure, medications like lithium, and iodine deficiency.
Clinical signs and symptoms are often non-specific but include fatigue, constipation, dry skin, hair loss, weight gain, feeling cold, muscle weakness, depression, and menstrual irregularities. Laboratory evaluation reveals elevated thyroid stimulating hormone (TSH) levels and low free T3 and T4 levels. Subclinical or mild hypothyroidism is defined as elevated TSH with normal thyroid hormone levels and may cause minimal or no symptoms. Treatment consists of thyroid hormone replacement with levothyroxine to bring TSH levels into the normal range. Regular monitoring is required for dose adjustments. Untreated hypothyroidism can lead to myxedema coma, a life-threatening emergency.
Hyperthyroidism
Hyperthyroidism occurs when the thyroid gland overproduces hormones, causing elevated free T3 and T4 levels and a suppressed TSH. Graves’ disease, an autoimmune disorder, is the most common cause, accounting for 70-80% of cases. Clinical features include weight loss despite increased appetite, heat intolerance, tremor, palpitations, anxiety, and irritability. On physical exam, thyroid gland may be diffusely enlarged and tremors may be evident. Laboratory tests reveal the aforementioned hormonal abnormalities as well as positive thyroid stimulating immunoglobulin in Graves’ disease.
Treatment involves anti-thyroid medications like methimazole or propylthiouracil to inhibit hormone synthesis, radioiodine ablation to destroy thyroid tissue, or surgery to remove part or all of the thyroid gland. Methimazole is usually first-line treatment due to easier reversibility compared to other modalities. Long-term complications if untreated include congestive heart failure, osteoporosis, andeye muscle damage. Anti-thyroid drug therapy may last 6-18 months depending on remission rate. Surgery or radioiodine ablation are selected for persistent or relapsing disease.
Diabetes Mellitus
Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. It has become a major public health problem worldwide due to increasing prevalence rates over recent decades.
Type 1 Diabetes
Type 1 diabetes (T1D), previously known as juvenile diabetes, is an autoimmune condition where the body’s immune system destroys the insulin-producing beta cells in the pancreas. It accounts for approximately 5-10% of diagnosed cases of diabetes. Onset is usually abrupt during childhood or adolescence but can occur at any age. Hallmark symptoms include polyuria, polydipsia, polyphagia, unexplained weight loss, blurred vision, fatigue, and vaginal infections. Diagnosis requires demonstration of hyperglycemia and presence of diabetes-related autoantibodies like islet cell antibodies. Treatment involves lifelong insulin replacement via multiple daily injections or continuous subcutaneous insulin infusion via an insulin pump. Strict glycemic control is important to prevent microvascular and macrovascular complications.
Type 2 Diabetes
Type 2 diabetes (T2D) develops due to insulin resistance coupled with relative insulin deficiency in genetically predisposed individuals. Obesity, sedentary lifestyle, older age, and family history are major risk factors. Symptoms are often mild and non-specific which delays diagnosis. Besides lifestyle modifications, available oral medications target improving insulin sensitivity or increasing insulin secretion from remaining pancreatic beta cells. When oral agents fail to adequately control blood sugars, addition of injectable medications like glucagon-like peptide-1 receptor agonists and insulin may be required. Intensive glycemic control has been shown to significantly reduce microvascular complications but weight gain is a common side effect.
Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are life-threatening emergencies seen mainly in T1D and T2D respectively, precipitated by insulin deficiency and excess counterregulatory hormones. Early recognition and prompt treatment with intravenous fluids and insulin replacement can greatly reduce in-hospital mortality from these conditions.
Other important endocrine topics
Addison’s disease: Chronic primary adrenal insufficiency causing hypotension, fatigue and hyperpigmentation due to deficiency of glucocorticoids and mineralocorticoids. Autoimmune destruction is the leading cause. Treatment involves lifelong glucocorticoid and mineralocorticoid replacement.
Cushing’s syndrome: Hypercortisolism from endogenous (pituitary or ectopic ACTH secretion) or exogenous (glucocorticoid exposure) causes. Signs include central obesity, moon face, purple striae, hypertension and osteoporosis. Urine and serum tests assess hormonal excess. Treatment dependent on underlying etiology.
Pituitary disorders: Numerous tumors and other abnormalities of the pituitary gland can cause deficiencies or excesses of hormones like growth hormone, ACTH, prolactin, TSH, gonadotropins leading to distinct clinical syndromes. Imaging and hormonal evaluations guide diagnosis and management. Surgery, radiation, medications may be used.
Male hypogonadism: Decreased testosterone level due to defects of testes or pituitary/hypothalamus impairs virilization and fertility. Signs include decreased libido, erectile dysfunction, low bone mineral density. Treatment with testosterone replacement improves symptoms and prevents complications.
PCOS: Common in women of reproductive age characterized by chronic anovulation and male pattern excess hair growth/acne due to elevated androgens. Insulin resistance is strongly implicated in pathogenesis. Treatment based on degree of symptomatology.
Conclusion
This paper explored the pathophysiology, clinical features, diagnostic evaluation, and management of some of the major endocrine disorders routinely encountered in clinical practice. Since hormonal imbalances can cause widespread metabolic derangements, timely recognition and appropriate treatment of endocrine disease states is crucial to prevent long term morbidity and mortality. Further research is ongoing to refine diagnosis and develop novel targeted therapies. Overall, a basic understanding of endocrinology is essential for all healthcare providers.
Andrew Stroud